ProCE Banner Activity

Recent Data on Immune Checkpoint Inhibition After Chemoradiotherapy in Unresectable Stage III NSCLC

Slideset Download
Examine recent clinical trial data on checkpoint inhibitors for unresectable stage III NSCLC in this expert-authored downloadable slideset.

Released: October 31, 2018

Expiration: October 30, 2019

No longer available for credit.

Share

Faculty

Karen L. Reckamp

Karen L. Reckamp, MD, MS

Associate Professor
Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, California

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

AstraZeneca

Faculty Disclosure

Primary Author

Karen L. Reckamp, MD, MS

Associate Professor
Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, California

Examine recent clinical trial data on checkpoint inhibitors for unresectable stage III NSCLC in this expert-authored downloadable slideset.